Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Acyclic nitrogen double bonded to acyclic nitrogen – acyclic...
Patent
1993-06-28
1997-09-30
Powers, Fiona
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Acyclic nitrogen double bonded to acyclic nitrogen, acyclic...
534550, 534551, 534552, 534553, 534554, A61K 31655
Patent
active
056725930
ABSTRACT:
The present invention is directed to bistriazene compounds, pharmaceutical compositions containing effective anti-cancer amounts of these compounds, a method for treating cancer comprising administering to affected subjects an anti-cancer effective amount of a bistriazene compound, and the use of bistriazene compounds as crosslinking reagents applicable to the synthesis and manipulation of polymeric macromolecules.
REFERENCES:
patent: 3138521 (1964-06-01), Jelinek et al.
patent: 3555004 (1971-01-01), Mueller et al.
patent: 4923970 (1990-05-01), Michejda et al.
Pochinok et al I, Chemical Abstracts, vol. 54, No. 13034i (1960).
Pochinok et al II, Chemical Abstracts, vol. 86, No. 188927k (1977).
Pochinok et al III, Chemical Abstracts, vol. 102, No. 61876m (1985).
Vilenskii et al, Chemical Abstracts, vol. 67, No. 27572h (1967).
Clarke et al (1955) Proc. Soc. Exp. Biol. Med. 90:484-88.
R.L. Comis, (1976) Cancer Treatment Reports 60:165-176.
Fiebig et al., I (1987) European Journal of Cancer and Clinical Oncology 23:937-948.
Fiebig et al. II (1989) Strahlenther. Onkol. 165:522-524.
B.T. Hill, (1987) Cancer Treatment Reviews 14:197-202.
Scalabrino et al. I (1981) in Klein et al., eds., Advances in Cancer Research vol. 35, Academic Press, New York, pp. 151-267.
Scalabrino et al., II (1982) in Klein et al., eds., Advances in Cancer Research vol. 36, Academic Press, New York, pp. 1-103.
A.E. Pegg, (1988) Cancer Research 48:759-774.
Randall et al. (1984) Journal Chem. Society Perkin Trans. II:251-253.
Schmiedekamp et al., (1988) Journal of Organic Chemistry 53:3433-3436.
Sieh et al. (1981) Journal of the American Chemical Society 103:442-445.
Smith et al., I (1984) Journal of the American Chemical Society 106:1056-1059.
Smith et al., II (1986) Journal of the American Chemical Society 108:3726-3730.
Smith et al III (1988) The Journal of Organic Chemistry 53:1467-1471.
Smith et al., IV (1986) The Journal of Organic Chemistry 51:3751-3757.
Smith et al. V (1989) The Journal of Organic Chemistry 54:1036-1042.
Vaughan et al., (1984) Journal of Medicinal Chemistry 27:357-363.
J.D. Watson (1987) Molecular Biology of the Gene, The Benjamin Cummings Publishing Company, Inc., Menlo Park, California pp. 346-347.
Pochinok et al (1977) Ukr. Khim. Zh. (Russ. Ed.) 43(2):180-183 (Russ.).
Grant & Hackh's Chemical Dictionary (1987) R. Grant et al eds., McGraw-Hill Book Company, New York, pp. 49, 53, 177, 282, 461, 558.
Koepke et al (1990) Chemical Research in Toxicology 3:17-20.
Sieh et al (1980) J. Am. Chem. Soc. 102:3883.
Blumenstein Jeffrey J.
Michejda Christopher J.
Powers Fiona
The United States of America as represented by the Department of
LandOfFree
Bistriazenes as chemotherapeutic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bistriazenes as chemotherapeutic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bistriazenes as chemotherapeutic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2256736